PuSH - Publication Server of Helmholtz Zentrum München

Moosmann, A. ; Bigalke, I. ; Tischer, J. ; Schirrmann, L. ; Kasten, J. ; Tippmer, S. ; Leeping, M. ; Prevalsek, D. ; Jaeger, G.* ; Ledderose, G. ; Mautner, J. ; Hammerschmidt, W. ; Schendel, D.J. ; Kolb, H.-J.

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells.

Blood 115, 2960-2970 (2010)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
Posttransplantation lymphoproliferative disease (PTLD) associated with Epstein-Barr virus (EBV) is a life-threatening complication after allogeneic hematopoietic stem cell transplantation. PTLD is efficiently prevented by adoptive transfer of EBV-specific T cells from the donor. To make EBV-specific T cells available in urgent clinical situations, we developed a rapid protocol for their isolation by overnight stimulation of donor blood cells with peptides derived from 11 EBV antigens, interferon-gamma surface capture, and immunomagnetic separation. Six patients with PTLD received 1 transfusion of EBV-specific T cells. No response was seen in 3 patients who had late-stage disease with multiorgan dysfunction at the time of T-cell transfer. In 3 patients who received T cells at an earlier stage of disease, we observed complete and stable remission of PTLD. Two patients have remained free from EBV-associated disease for more than 2 years. CD8(+) T cells specific for EBV early antigens rapidly expanded after T-cell transfer, temporarily constituted greater than 20% of all peripheral blood lymphocytes, and were maintained throughout the observation period. Thus, a rapid and sustained reconstitution of a protective EBV-specific T-cell memory occurred after the infusion of small numbers of directly isolated EBV-specific T cells.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Epstein-barr-virus; Posttransplantation lymphoproliferative disease; Monoclonal-antibody rituximab; Adoptive transfer; Transplant recipients; Adenovirus infection; Lytic infection; Cycle proteins; Helper-cells; High-risk
ISSN (print) / ISBN 0006-4971
e-ISSN 1528-0020
Journal Blood
Quellenangaben Volume: 115, Issue: 14, Pages: 2960-2970 Article Number: , Supplement: ,
Publisher American Society of Hematology
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Institute of Molecular Immunology (IMI)
CCG Immune Monitoring (Platform) (IMI-KIM)